mitoxantrone , a new anthracenedione , was administered to thirty-nine patients with relapsed and refractory acute leukemia and to 12 patients with blastic crisis of chronic myelogenous leukemia between august 1981 and september 1984 .
C0026259
mitoxantrone
C0003174
anthracenedione